NCT06913959Not yet recruiting
HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 220 (estimated)
- First submitted
- 31 Mar 2025
- Start date
- 1 Dec 2026
- Primary completion date
- 1 Jul 2027
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Diseases
- HIV
- NCT number
- NCT06913959
What you commit to
- Study type: Observational
- Planned participants: 220
- From 1 Dec 2026 to the primary completion date, 1 Jul 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- All HIV-positive individuals aged less than 21 years, infected with a Group M HIV-1 virus, or those who refused to participate in the study
Other
- Insufficient quantity or degraded Dried Blood Spot samples
Who the study is looking for
- All available samples tested positive for HIV during the national Health survey of Cameroon in 2011 And 2018
- All Individuals who came to Centre Pasteur in Yaoundé or Garoua for HIV screening or viral load monitoring.
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.